NASDAQ · Financial Statements

OptimizeRx Corporation (OPRX) Financial Statements

$9.15 NASDAQ: OPRX Market Cap $172.35M

OptimizeRx Corporation most recently reported annual revenue of $109.0M, net profit of $5.0M. Revenue grew at an average annual rate of 20.4% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.

OptimizeRx Corporation: Revenue rose from $8.0M in 2016 to $109.0M in 2025, a change of +1262.5% over 9 years; net profit was positive in 1 of 10 reported years; operating margin moved from -20.4% to 11.0%, a shift of +31.4 percentage points; the most recent year shows net profit of $5.0M.

Income Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Revenue$8.0M$12.0M$21.0M$25.0M$43.0M$61.0M$62.0M$72.0M$92.0M$109.0M
Operating Expenses$9.0M$14.0M$21.0M$28.0M$45.0M$61.0M$75.0M$98.0M$106.0M$97.0M
Operating Profit$-2.0M$-2.0M$0$-4.0M$-2.0M$0$-12.0M$-26.0M$-14.0M$12.0M
Operating Margin-20.4%-17.6%0.8%-15.0%-4.9%0.6%-19.7%-36.9%-14.9%11.0%
Other Income$0$0$0$1.0M$0$0$1.0M$1.0M$-6.0M$-5.0M
Interest$0$0$0$0$0$0$0$1.0M$6.0M$5.0M
Depreciation$0$0$0$1.0M$2.0M$2.0M$2.0M$2.0M$4.0M$4.0M
Profit Before Tax$-2.0M$-2.0M$0$-2.0M$-2.0M$0$-11.0M$-25.0M$-19.0M$7.0M
Tax$0$0$0$-40.0M$0$0$0$30.2M$-3.7M$26.2M
Net Profit$-2.0M$-2.0M$0$-3.0M$-2.0M$0$-11.0M$-18.0M$-20.0M$5.0M
EPS$-0.16$-0.21$0.02$-0.23$-0.15$0.02$-0.64$-1.03$-1.10$0.27
Dividend Payout0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%0.0%

Quarterly Results — Last 12 Quarters (USD millions)

8 duplicate period labels in the source data were collapsed.

MetricSep '23Dec '23Mar '24Jun '24Sep '24Dec '24Mar '25Jun '25Sep '25Dec '25Mar '26Jun '26
Revenue$16.0M$28.0M$20.0M$19.0M$21.0M$32.0M$22.0M$29.0M$26.0M$32.0M$20.0M$21.0M
Operating Expenses$20.0M$39.0M$25.0M$23.0M$30.0M$29.0M$24.0M$26.0M$24.0M$23.0M$19.0M$21.0M
Operating Profit$-4.0M$-11.0M$-5.0M$-4.0M$-9.0M$4.0M$-2.0M$3.0M$2.0M$9.0M$0$0
Operating Margin-21.8%-38.4%-25.5%-19.9%-40.2%11.3%-9.6%10.9%7.9%27.7%2.0%-0.4%
Interest$0$1.0M$2.0M$2.0M$2.0M$2.0M$1.0M$2.0M$1.0M$1.0M$1.0M$1.0M
Profit Before Tax$-3.0M$-12.0M$-7.0M$-5.0M$-10.0M$2.0M$-3.0M$2.0M$1.0M$7.0M$-1.0M$-1.0M
Tax$0$64.7M$-5.3M$21.4M$8.2M$103.5M$33.0M$10.6M$25.7M$32.8M$23.1M$35.9M
Net Profit$-3.0M$-4.0M$-7.0M$-4.0M$-9.0M$0$-2.0M$2.0M$1.0M$5.0M$0$-1.0M
EPS$-0.17$-0.23$-0.38$-0.22$-0.50$0.00$-0.12$0.08$0.04$0.26$-0.03$-0.04

Over the 10 years reported for OptimizeRx Corporation, cash stood at $23.0M in the latest year, shareholders' equity was $0, current assets covered current liabilities 3.10 times.

Balance Sheet — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Total Assets$11.0M$10.0M$25.0M$57.0M$60.0M$141.0M$135.0M$183.0M$171.0M$177.0M
Current Assets$10.0M$9.0M$16.0M$27.0M$33.0M$115.0M$99.0M$54.0M$54.0M$65.0M
Cash$7.0M$5.0M$9.0M$19.0M$11.0M$85.0M$18.0M$14.0M$13.0M$23.0M
Inventory$0$0$0$0$0$0$0$0$0$0
Receivables$3.0M$3.0M$6.0M$7.0M$18.0M$25.0M$22.0M$37.0M$38.0M$39.0M
Fixed Assets$0$0$0$1.0M$1.0M$0$0$1.0M$1.0M$1.0M
Capital Work in Progress$0$0$0$0$0$0$0$0$0$0
Investments$0$0$0$0$0$0$56.0M$0$0$0
Other Assets$0$0$4.0M$15.0M$15.0M$15.0M$23.0M$78.0M$71.0M$71.0M
Total Liabilities$4.0M$4.0M$7.0M$12.0M$10.0M$10.0M$9.0M$57.0M$54.0M$49.0M
Current Liabilities$4.0M$4.0M$4.0M$6.0M$10.0M$9.0M$8.0M$18.0M$19.0M$21.0M
Borrowings$0$0$0$1.0M$0$0$0$37.0M$33.0M$26.0M
Other Liabilities$4.0M$4.0M$7.0M$11.0M$10.0M$9.0M$8.0M$20.0M$21.0M$23.0M
Equity$0$0$0$0$0$0$0$0$0$0
Reserves$8.0M$6.0M$18.0M$45.0M$50.0M$131.0M$126.0M$127.0M$117.0M$128.0M

For OptimizeRx Corporation, operating cash flow was positive in 5 of 10 reported years; free cash flow in the latest year was $19.0M; free cash flow was positive in 4 of 10 years; financing activities used $1.0M in the latest year, which covers debt repayment, dividends and buybacks.

Cash Flow Statement — 10 Years (USD millions)

Metric2016201720182019202020212022202320242025
Operating Cash Flow$0$-1.0M$1.0M$-2.0M$-6.0M$1.0M$11.0M$-7.0M$5.0M$19.0M
Investing Cash Flow$-1.0M$0$-6.0M$-12.0M$0$-1.0M$-58.0M$-26.0M$-1.0M$0
Financing Cash Flow$-1.0M$0$1.0M$1.0M$-4.0M$3.0M$-19.0M$-8.0M$-1.0M$-1.0M
Net Cash Flow$-1.0M$-2.0M$4.0M$10.0M$-8.0M$74.0M$-66.0M$-4.0M$0$10.0M
Free Cash Flow$-1.0M$-2.0M$1.0M$-3.0M$-6.0M$0$10.0M$-8.0M$5.0M$19.0M

Valuation & Return Ratios

MetricValue
PEG Ratio0.00
EV / EBITDA10.01
FCF Yield11.41%
Quick Ratio5.58
Interest Coverage2.42
Return 1Y-48.50%
Return 3Y-55.70%
Return 5Y-87.18%

OptimizeRx Corporation (OPRX) financials — frequently asked questions

What is OptimizeRx Corporation's annual revenue?

OptimizeRx Corporation (OPRX) reported annual revenue of $109.0M in its most recent fiscal year.

What is OptimizeRx Corporation's net profit?

OptimizeRx Corporation (OPRX) reported net profit of $5.0M in its most recent fiscal year.

What is OPRX EV/EBITDA?

OptimizeRx Corporation's enterprise value to EBITDA (EV/EBITDA) ratio is 10.01.

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)Eli Lilly (LLY)JPMorgan (JPM)

Related stock screens

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksHigh ROE StocksLow P/E StocksHigh Net Margin StocksDividend StocksLow Debt StocksNasdaq High ROE StocksAll stock screens
OPRX Overview OPRX Dividend Run Stock Screener

Data for information only, not investment advice. Figures may be delayed or inaccurate; verify against company filings. See our disclaimer.